These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37020516)

  • 1. Case report: CAR-T cell therapy-induced cardiac tamponade.
    Sarfati S; Eugène Norbert M; Hérault A; Giry M; Makké J; Grall M; Savouré A; Camus V; Alani M; Tamion F; Latouche JB; Girault C
    Front Cardiovasc Med; 2023; 10():1132503. PubMed ID: 37020516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case Report: Cardiac Tamponade in Association With Cytokine Release Syndrome Following CAR-T Cell Therapy.
    Moriyama S; Fukata M; Yokoyama T; Ueno S; Nunomura T; Mori Y; Kato K; Miyamoto T; Akashi K
    Front Cardiovasc Med; 2022; 9():848091. PubMed ID: 35387436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chylothorax after chimeric antigen receptor T cell therapy for relapsed and refractory diffuse large B-cell lymphoma: A case report.
    Chen HH; Kuo CY; Ho CL; Chen YC
    Medicine (Baltimore); 2023 Oct; 102(41):e35432. PubMed ID: 37832125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.
    Ernst M; Oeser A; Besiroglu B; Caro-Valenzuela J; Abd El Aziz M; Monsef I; Borchmann P; Estcourt LJ; Skoetz N; Goldkuhle M
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013365. PubMed ID: 34515338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD19 and CD70 Dual-Target Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Relapsed and Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma.
    Tu S; Zhou X; Guo Z; Huang R; Yue C; He Y; Li M; Chen Y; Liu Y; Chang LJ; Li Y
    Front Oncol; 2019; 9():1350. PubMed ID: 31867275
    [No Abstract]   [Full Text] [Related]  

  • 6. Cervical Local Cytokine Release Syndrome Following Chimeric Antigen Receptor T-cell Therapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma.
    Inoue Y; Fujino T; Chinen S; Niiyama-Uchibori Y; Ide D; Kawata M; Hashimoto K; Takimoto-Shimomura T; Nakayama A; Tsukamoto T; Mizutani S; Shimura Y; Hirano S; Kuroda J
    Cureus; 2023 May; 15(5):e38905. PubMed ID: 37303362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas.
    Zhou X; Tu S; Wang C; Huang R; Deng L; Song C; Yue C; He Y; Yang J; Liang Z; Wu A; Li M; Zhou W; Du J; Guo Z; Li Y; Jiao C; Liu Y; Chang LJ; Li Y
    Front Immunol; 2020; 11():564099. PubMed ID: 33329526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediastinal effusion due to pericardiocentesis with cardiac tamponade: a case report.
    Zhang Q; Wang D; Liu Y
    BMC Anesthesiol; 2021 Jun; 21(1):172. PubMed ID: 34134618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual specific CD19/CD22-targeted chimeric antigen receptor T-cell therapy for refractory diffuse large B-cell lymphoma: A case report.
    Huang C; Zhang HC; Ho JY; Liu RX; Wang L; Kuang N; Zheng MR; Liu LH; Li JQ
    Oncol Lett; 2020 Oct; 20(4):21. PubMed ID: 32774494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-Onset Hemorrhagic Pericardial Effusion and Cardiac Tamponade Associated With Immune Checkpoint Inhibitors: Case Report and Literature Review.
    Khachatryan A; Alejandro JM; Chow RD; Haque RU; Mikdashi JA
    Cureus; 2023 Aug; 15(8):e42867. PubMed ID: 37664293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Cardiac Tamponade as a Complication of Pulmonary Vein Isolation Ablation.
    Tsai J; Chishinga N; Velutha Mannil S; Schaffer R; Kuchciak A; Gomez SI; Dylewski J; Sciarra J
    Cureus; 2021 Nov; 13(11):e19572. PubMed ID: 34926044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Takotsubo cardiomyopathy complicated by cardiac tamponade due to non-hemorrhagic pericardial effusion: a case report.
    Nagamori Y; Hamaoka T; Murai H; Takashima S; Kato T; Usui S; Sakata K; Furusho H; Kawashiri M; Takamura M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):67. PubMed ID: 32028901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of CD19-Directed Chimeric Antigen Receptor T Cell Therapy for Transformed Nonfollicular Lymphoma.
    Dong N; Rubio Lopes-Garcia L; Viñal D; Bachmeier C; Shah BD; Nishihori T; Khimani F; Davila ML; Lazaryan A; Pinilla-Ibarz J; Locke FL; Jain MD; Chavez JC
    Transplant Cell Ther; 2023 Jun; 29(6):349.e1-349.e8. PubMed ID: 36878427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Influenza B Infection Presenting as Cardiac Tamponade: A Case Report.
    Arfaras-Melainis A; Cordero H; Goyal A; Benes L; Salgunan R
    Cureus; 2020 Nov; 12(11):e11799. PubMed ID: 33409044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pericardial tamponade: A comprehensive emergency medicine and echocardiography review.
    Alerhand S; Adrian RJ; Long B; Avila J
    Am J Emerg Med; 2022 Aug; 58():159-174. PubMed ID: 35696801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac tamponade due to low-volume effusive constrictive pericarditis in a patient with uncontrolled type II autoimmune polyglandular syndrome.
    Palmer WC; Kurklinsky A; Lane G; Ussavarungsi K; Blackshear JL
    Acute Card Care; 2014 Mar; 16(1):23-7. PubMed ID: 24552226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of co-administration of CD19- and CD20-targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma.
    Sang W; Shi M; Yang J; Cao J; Xu L; Yan D; Yao M; Liu H; Li W; Zhang B; Sun K; Song X; Sun C; Jiao J; Qin Y; Sang T; Ma Y; Wu M; Gao X; Cheng H; Yan Z; Li D; Sun H; Zhu F; Wang Y; Zeng L; Li Z; Zheng J; Xu K
    Cancer Med; 2020 Aug; 9(16):5827-5838. PubMed ID: 32608579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Preemptive Use of Tocilizumab on Chimeric Antigen Receptor T Cell Outcomes in Non-Hodgkin Lymphoma.
    De Philippis C; Mannina D; Giordano L; Costantini E; Marcheselli S; Mariotti J; Sarina B; Taurino D; Santoro A; Bramanti S
    Transplant Cell Ther; 2023 Jul; 29(7):429.e1-429.e6. PubMed ID: 36966874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Tamponade: An Initial Manifestation of Diffuse Large B Cell Lymphoma.
    Arty F; Chinchanikar S; Khan MA; Tamanna N; Anwar D; Shah SM
    Cureus; 2024 May; 16(5):e60418. PubMed ID: 38882999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Management of Effusions Before and After CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Large B Cell Lymphoma.
    Mirza AS; Kumar A; Hashmi H; Garcia F; Logothetis CN; Darwin A; Faramand R; Reid K; Bachmeier C; Chavez JC; Shah B; Pinilla-Ibarz J; Khimani F; Lazaryan A; Liu H; Davila ML; Nishihori T; Locke FL; Jain MD
    Transplant Cell Ther; 2021 Mar; 27(3):242.e1-242.e6. PubMed ID: 33781520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.